• Overview
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Atrial Fibrillation 2012: New Developments in Risk Stratification and Antithrombotics to Prevent Stroke

Atrial Fibrillation 2012: New Developments in Risk Stratification and Antithrombotics to Prevent Stroke

Format

Webcast

Time to Complete

1 hour

Released

October 1, 2012

Expires

September 30, 2014

Maximum Credits

1.00 / AMA PRA Category 1 Credit(s)TM

Accredited Provider

National Association for Continuing Education

Commercial Supporter

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Program Description

Atrial fibrillation (AF) is the most common type of cardiac arrhythmia requiring medical care. About 2.2 million Americans are affected, with the elderly being more commonly involved. The prevalence of the condition is increasing, and the number of AF patients is likely to increase 2.5-fold during the next 50 years, reflecting the growing proportion of elderly individuals. AF is an independent risk factor for stroke, increasing the risk about 5-fold. AF is responsible for about 15-20% of all strokes, and accounts for one-fourth of strokes in the elderly. Over 700,000 Americans suffer from a stroke each year, and the direct and indirect costs of stroke care exceed $51 billion. AF independently increases the risk of death. Many health care providers have significant knowledge gaps involving stroke risk assessment, indications for use of anticoagulants, and understanding of the risk vs benefit of anticoagulation. These and other gaps will be addressed in this CME activity.

Welcome to the National Association for Continuing Education webcast from the NACE Emerging Challenges in Primary Care Update: 2012 conference. The topic of this webcast is Atrial Fibrillation 2012: New Developments in Risk Stratification and Antithrombotics to Prevent Stroke.

The program was captured live in Denver, Colorado on June 16, 2012 and features Dr. Louis Kuritzky. Dr. Kuritzky is a Clinical Assistant Professor in the Department of Community Health and Family Medicine at the University of Florida in Gainesville, FL.

Intended Audience

Primary care providers

Educational Objectives

After completing this program, participants should be better able to:

  • Use the CHADS2 score to assess stroke risk in patients with atrial fibrillation (AF)
  • Describe the benefits vs risks of antithrombotic therapy for stroke risk reduction in AF patients
  • Identify appropriate therapeutic interventions for AF patients depending on the level of stroke risk
  • Optimize the long-term management of AF patients receiving antithrombotic therapy

Faculty

Louis Kuritzky, MD
Clinical Assistant Professor
Department of Community Health & Family Medicine
University of Florida
Gainesville, FL

Louis Kuritzky, MD, Speaker, is a consultant/advisor for Lilly, Boehringer Ingelheim, and Jannssen (Dr. Kuritsky's relationships with the companies listed are regarding products unrelated to the topic he is presenting.)

Jan Basile, MD, Speaker, is on the speaker's bureaus for Boehringer Ingelheim/Lilly, Daiichi Sankyo, Forest Labs, and Takeda. He is also a consultant for Daiichi Sankyo, Forest Labs, and Takeda.

Elizabeth A. Jackson, MD, MPH, Speaker, has no relationships to disclose.

Harvey C. Parker, PhD, Activity Planning Committee, has the following relationship to disclose: co-owner of Specialty Press, Inc. and Health Link Systems, Inc.

Gregg Sherman, MD, Co-Course Director, has no relationships to disclose.

Deborah Paschal, CRNP, Co-Course Director, has no relationships to disclose.

Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose.

Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The National Association for Continuing Education designates this educational activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Instructions

To obtain credit, a score of 60% or better is required. This CE is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test, and received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.

Privacy Policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Click the "Start Activity" button to indicate you have reviewed the CME/CE information for this activity.
Add to Queue